2-(溴甲基)荧蒽 | 88746-58-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 2-(溴甲基)荧蒽
• 中文别名: 4'-氟-4-三氟甲氧基二苯甲酮
• 英文名称: 2-(bromomethyl)fluoranthene
• 英文别名: 2-bromomethylfluoranthene
• CAS: 88746-58-1
• 化学式: C₁₇H₁₁Br
• 分子量: 295.178
• InChiKey: OBPLBICJMCINMR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

安全信息

• 海关编码：
  2903999090

反应信息

• 作为反应物：
  描述：

  2-(溴甲基)荧蒽 在 盐酸 sodium hydroxide 、 lithium aluminium tetrahydride 、 三氯化铝 、 草酰氯 、 双氧水 、 silver nitrate 、 pyridinium chlorochromate 、 diborane(6) 作用下， 以 四氢呋喃 、 二硫化碳 、 乙醚 、 二氯甲烷 、 水 、 溶剂黄146 为溶剂， 反应 41.5h， 生成 9,10-dihydrobenzofluoranthene
  参考文献：
  名称：

  A study of chemical carcinogenesis. 57. Synthesis and mutagenicity of dihydrodiol metabolites of benzo[b]fluoranthene

  摘要：

  DOI：

  10.1021/jo00180a026
• 作为产物：
  描述：

  2-甲基荧蒽 在 N-溴代丁二酰亚胺(NBS) 、 过氧化氢苯甲酰 作用下， 以 四氯化碳 为溶剂， 反应 2.5h， 生成 2-(溴甲基)荧蒽
  参考文献：
  名称：

  2-[(Arylmethyl)amino]-2-methyl-1,3-propanediol DNA intercalators. An examination of the effects of aromatic ring variation on antitumor activity and DNA binding

  摘要：

  The effects of variation of aromatic ring size, shape, and side-chain position on antitumor activity and DNA binding in a series of carbocyclic 2-[(arylmethyl)amino]-2-methyl-1,3-propanediols (AMAPs) were examined. In general, the interaction of AMAPs with DNA increases as the intercalating ring system grows in area, with three distinct binding levels evident. Isomers from a specific ring system appear to bind DNA similarly. DNA binding is not the sole criterion for antitumor activity for the AMAPs studied; the magnitude of the DELTA-T(m) does not correlate with the antitumor activity observed. Significant in vivo P388 activity was seen for AMAP congeners from several tetracyclic ring systems. However, isomers from each of the specific ring systems produced a wide range of in vivo P388 activity. Thus, AMAP antitumor activity is not a function of the ring system per se, but rather appears to be related to the shape of the specific molecule. Three AMAP congeners (crisnatol (770U82, 773U82, and 502U83) are currently in clinical trials.

  DOI：

  10.1021/jm00111a010

文献信息

• A study of chemical carcinogenesis. 84. Synthesis and fluorescence spectra of structural analogs of potential benzo[b]fluoranthene-DNA adducts
  作者：Shantu Amin、George Balanikas、Keith Huie、Nalband Hussain、J. Edgar Geddie、Stephen S. Hecht

  DOI：10.1021/jo00223a046

  日期：1985.11
• AMIN, S.;HUSSAIN, N.;BRIELMANN, H.;HECHT, S. S., J. ORG. CHEM., 1984, 49, N 6, 1091-1095
  作者：AMIN, S.、HUSSAIN, N.、BRIELMANN, H.、HECHT, S. S.

  DOI：——

  日期：——
• AMIN, S.;BALANIKAS, G.;HUIE, K.;HUSSAIN, N.;GEDDIE, E.;HECHT, S. S., J. ORG. CHEM., 1985, 50, N 23, 4642-4646
  作者：AMIN, S.、BALANIKAS, G.、HUIE, K.、HUSSAIN, N.、GEDDIE, E.、HECHT, S. S.

  DOI：——

  日期：——
• US5241107A
  申请人：——

  公开号：US5241107A

  公开（公告）日：1993-08-31
• 2-[(Arylmethyl)amino]-2-methyl-1,3-propanediol DNA intercalators. An examination of the effects of aromatic ring variation on antitumor activity and DNA binding
  作者：Kenneth W. Bair、C. Webster Andrews、Richard L. Tuttle、Vincent C. Knick、Michael Cory、David D. McKee

  DOI：10.1021/jm00111a010

  日期：1991.7

  The effects of variation of aromatic ring size, shape, and side-chain position on antitumor activity and DNA binding in a series of carbocyclic 2-[(arylmethyl)amino]-2-methyl-1,3-propanediols (AMAPs) were examined. In general, the interaction of AMAPs with DNA increases as the intercalating ring system grows in area, with three distinct binding levels evident. Isomers from a specific ring system appear to bind DNA similarly. DNA binding is not the sole criterion for antitumor activity for the AMAPs studied; the magnitude of the DELTA-T(m) does not correlate with the antitumor activity observed. Significant in vivo P388 activity was seen for AMAP congeners from several tetracyclic ring systems. However, isomers from each of the specific ring systems produced a wide range of in vivo P388 activity. Thus, AMAP antitumor activity is not a function of the ring system per se, but rather appears to be related to the shape of the specific molecule. Three AMAP congeners (crisnatol (770U82, 773U82, and 502U83) are currently in clinical trials.